Michigan Neuropathy Screening Instrument (MNSI)

• Published in 1994

The Michigan Neuropathy Screening Instrument (MNSI) is designed to screen for the presence of diabetic neuropathy. The MNSI is designed to be used in an outpatient setting by primary care or other providers

The first part of the screening instrument, the history questionnaire, consists of 15 self-administered "yes or no" questions on foot sensation including pain, numbness and temperature sensitivity. A higher score (out of a maximum of 13 points) indicates more neuropathic symptoms

The questions were chosen from among those in the Neuropathy Screening Profile of Peter Dyck that showed the highest degree of specificity and sensitivity for diabetic neuropathy among normal subjects and those with a variety of neuromuscular disorders (Neurology, 36:1300-1308, 1986)

The second part of the MNSI is a brief physical assessment (completed by health professionals) involving
1) inspection of the feet for deformities, dry skin, hair or nail abnormalities, callous or infection
2) semi-quantitative assessment of vibration sensation at the dorsum of the great toe
3) grading of ankle reflexes and
4) monofilament testing.
Patients screening positive on the clinical portion of the MNSI (greater than 2 points on a 10 point scale) are considered neuropathic and referred for further evaluation

Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289 (PubMed Abstract)

Michigan Diabetes Research Center

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

• MNSI in English for the USA

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

The user can translate the instrument and special permission from Owner is not needed.
User shall send a copy of the translations to the Owner when completed.

Also, the Owner asks that user cites their Center: "The project described was supported by Grant Number P30DK020572 (Michigan Diabetes Research Center (MDRC)) from the National Institute of Diabetes and Digestive and Kidney Diseases" Or “The project described was supported by Grant Number P30DK092926 (Michigan Diabetes Research Center (MDRC)) from the National Institute of Diabetes and Digestive and Kidney Diseases.”

Bibliographic references of the translations:

Chinese:
Jia WP, Shen Q, Bao YQ, Lu JX, Li M, Xiang KS. [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy] Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2707-10. Chinese (PubMed abstract)
Portuguese:
Barbosa M, Saavedra A, Severo M, Maier C, Carvalho D. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument. Pain Pract. 2017 Apr;17(4):514-521 (PubMed abstract)
Turkish:
Aktar Reyhanioğlu D, Adiyaman SC, Bektaş M, Bulut O, Özgen Saydam B, Bayraktar F, Kara B. Turkish validity and reliability of the Michigan Neuropathy Screening Instrument. Turk J Med Sci. 2020 Mar 17;50(4):789–97 (Full text article)